Neupro (rotigotine)-Important Information from UCB (Pharma) on the recall of certain packs
11 June 2008
Please find herewith an important safety notification from UCB(Pharma) Ireland Limited relating to the manufacture of Neupro (rotigotine transdermal patch) which resulted in a recall of certain affected batches of the product across Europe. Neupro is indicated for the treatment of the signs and symptoms of early-stage and advanced-stage idiopathic Parkinson's disease.